Coapt Systems, Inc. Launches ENDOTINE Midface Bone 4.5 For Vertical Midface Suspension; Fifth In A Series Of New ENDOTINE Product Offerings
10/19/2005 5:10:51 PM
PALO ALTO, Calif.--(BUSINESS WIRE)--April 28, 2005--Coapt Systems, Inc., developer of bioabsorbable implants for the fixation of soft tissue in the plastic and reconstructive surgery markets, announced today that it has released the ENDOTINE Midface(TM) Bone 4.5 for commercial sale in the U.S. market to coincide with the annual congress of the American Society of Aesthetic and Plastic Surgeons (ASAPS) that begins in New Orleans, Louisiana this week.
"This product is the fifth in a series of new products that we will launch over the next twelve months that will enable us to build an enduring franchise in the plastic surgery market," said John Kraczkowsky, Senior Vice President, Sales and Marketing. "The ENDOTINE Midface Bone product provides our customers with another option to suspend the midface that has many advantages when compared to prior suspension techniques. This new device completes our midface product offering, now enabling surgeons to elevate the cheek in any direction from vertical to oblique."